HomeNGNE • NASDAQ
add
Neurogene Inc
Previous close
$21.16
Day range
$20.19 - $22.06
Year range
$6.88 - $37.27
Market cap
314.13M USD
Avg Volume
260.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.56M | 11.23% |
Net income | -20.95M | -3.64% |
Net profit margin | — | — |
Earnings per share | -0.99 | — |
EBITDA | -23.02M | -7.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 265.41M | 90.95% |
Total assets | 287.83M | 75.38% |
Total liabilities | 22.29M | -16.53% |
Total equity | 265.54M | — |
Shares outstanding | 15.49M | — |
Price to book | 1.18 | — |
Return on assets | -20.33% | — |
Return on capital | -21.25% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -20.95M | -3.64% |
Cash from operations | -19.51M | -25.34% |
Cash from investing | 21.99M | 175.92% |
Cash from financing | 9.71M | 7,312.21% |
Net change in cash | 12.19M | 127.46% |
Free cash flow | -12.20M | -62.13% |
About
Founded
2018
Website
Employees
107
